Cargando…
Isolation of tumour stem-like cells from benign tumours
BACKGROUND: Cancerous stem-like cells (CSCs) have been implicated as cancer-initiating cells in a range of malignant tumours. Diverse genetic programs regulate CSC behaviours, and CSCs from glioblastoma patients are qualitatively distinct from each other. The intrinsic connection between the presenc...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720199/ https://www.ncbi.nlm.nih.gov/pubmed/19568241 http://dx.doi.org/10.1038/sj.bjc.6605142 |
_version_ | 1782170114501640192 |
---|---|
author | Xu, Q Yuan, X Tunici, P Liu, G Fan, X Xu, M Hu, J Hwang, J Y Farkas, D L Black, K L Yu, J S |
author_facet | Xu, Q Yuan, X Tunici, P Liu, G Fan, X Xu, M Hu, J Hwang, J Y Farkas, D L Black, K L Yu, J S |
author_sort | Xu, Q |
collection | PubMed |
description | BACKGROUND: Cancerous stem-like cells (CSCs) have been implicated as cancer-initiating cells in a range of malignant tumours. Diverse genetic programs regulate CSC behaviours, and CSCs from glioblastoma patients are qualitatively distinct from each other. The intrinsic connection between the presence of CSCs and malignancy is unclear. We set out to test whether tumour stem-like cells can be identified from benign tumours. METHODS: Tumour sphere cultures were derived from hormone-positive and -negative pituitary adenomas. Characterisation of tumour stem-like cells in vitro was performed using self-renewal assays, stem cell-associated marker expression analysis, differentiation, and stimulated hormone production assays. The tumour-initiating capability of these tumour stem-like cells was tested in serial brain tumour transplantation experiments using SCID mice. RESULTS: In this study, we isolated sphere-forming, self-renewable, and multipotent stem-like cells from pituitary adenomas, which are benign tumours. We found that pituitary adenoma stem-like cells (PASCs), compared with their differentiated daughter cells, expressed increased levels of stem cell-associated gene products, antiapoptotic proteins, and pituitary progenitor cell markers. Similar to CSCs isolated from glioblastomas, PASCs are more resistant to chemotherapeutics than their differentiated daughter cells. Furthermore, differentiated PASCs responded to stimulation with hypothalamic hormones and produced corresponding pituitary hormones that are reflective of the phenotypes of the primary pituitary tumours. Finally, we demonstrated that PASCs are pituitary tumour-initiating cells in serial transplantation animal experiments. CONCLUSION: This study for the first time indicates that stem-like cells are present in benign tumours. The conclusions from this study may have applications to understanding pituitary tumour biology and therapies, as well as implications for the notion of tumour-initiating cells in general. |
format | Text |
id | pubmed-2720199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-27201992010-07-21 Isolation of tumour stem-like cells from benign tumours Xu, Q Yuan, X Tunici, P Liu, G Fan, X Xu, M Hu, J Hwang, J Y Farkas, D L Black, K L Yu, J S Br J Cancer Molecular Diagnostics BACKGROUND: Cancerous stem-like cells (CSCs) have been implicated as cancer-initiating cells in a range of malignant tumours. Diverse genetic programs regulate CSC behaviours, and CSCs from glioblastoma patients are qualitatively distinct from each other. The intrinsic connection between the presence of CSCs and malignancy is unclear. We set out to test whether tumour stem-like cells can be identified from benign tumours. METHODS: Tumour sphere cultures were derived from hormone-positive and -negative pituitary adenomas. Characterisation of tumour stem-like cells in vitro was performed using self-renewal assays, stem cell-associated marker expression analysis, differentiation, and stimulated hormone production assays. The tumour-initiating capability of these tumour stem-like cells was tested in serial brain tumour transplantation experiments using SCID mice. RESULTS: In this study, we isolated sphere-forming, self-renewable, and multipotent stem-like cells from pituitary adenomas, which are benign tumours. We found that pituitary adenoma stem-like cells (PASCs), compared with their differentiated daughter cells, expressed increased levels of stem cell-associated gene products, antiapoptotic proteins, and pituitary progenitor cell markers. Similar to CSCs isolated from glioblastomas, PASCs are more resistant to chemotherapeutics than their differentiated daughter cells. Furthermore, differentiated PASCs responded to stimulation with hypothalamic hormones and produced corresponding pituitary hormones that are reflective of the phenotypes of the primary pituitary tumours. Finally, we demonstrated that PASCs are pituitary tumour-initiating cells in serial transplantation animal experiments. CONCLUSION: This study for the first time indicates that stem-like cells are present in benign tumours. The conclusions from this study may have applications to understanding pituitary tumour biology and therapies, as well as implications for the notion of tumour-initiating cells in general. Nature Publishing Group 2009-07-21 2009-06-30 /pmc/articles/PMC2720199/ /pubmed/19568241 http://dx.doi.org/10.1038/sj.bjc.6605142 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Molecular Diagnostics Xu, Q Yuan, X Tunici, P Liu, G Fan, X Xu, M Hu, J Hwang, J Y Farkas, D L Black, K L Yu, J S Isolation of tumour stem-like cells from benign tumours |
title | Isolation of tumour stem-like cells from benign tumours |
title_full | Isolation of tumour stem-like cells from benign tumours |
title_fullStr | Isolation of tumour stem-like cells from benign tumours |
title_full_unstemmed | Isolation of tumour stem-like cells from benign tumours |
title_short | Isolation of tumour stem-like cells from benign tumours |
title_sort | isolation of tumour stem-like cells from benign tumours |
topic | Molecular Diagnostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720199/ https://www.ncbi.nlm.nih.gov/pubmed/19568241 http://dx.doi.org/10.1038/sj.bjc.6605142 |
work_keys_str_mv | AT xuq isolationoftumourstemlikecellsfrombenigntumours AT yuanx isolationoftumourstemlikecellsfrombenigntumours AT tunicip isolationoftumourstemlikecellsfrombenigntumours AT liug isolationoftumourstemlikecellsfrombenigntumours AT fanx isolationoftumourstemlikecellsfrombenigntumours AT xum isolationoftumourstemlikecellsfrombenigntumours AT huj isolationoftumourstemlikecellsfrombenigntumours AT hwangjy isolationoftumourstemlikecellsfrombenigntumours AT farkasdl isolationoftumourstemlikecellsfrombenigntumours AT blackkl isolationoftumourstemlikecellsfrombenigntumours AT yujs isolationoftumourstemlikecellsfrombenigntumours |